Germanium used to be readily available around the globe, but it was taken off the shelves in a number of countries after some practitioners, and patients themselves, started using it to treat cancer, and after reports of kidney damage surfaced from using germanium dioxide, following its supplementation. However, the organo-germanium form, bis-carboxyethyl germanium sesquioxide, developed by Kazuhiko Asaia of Japan in 1967, is a safe and effective compound that can be used for a variety of medical problems ranging from viral infections to cancer, which require improved oxygenation and immune support. GE-132 is further known to enhance the immune system by stimulating the production of natural killer cells and lymphokines such as IFN, interferon, macrophages, and T-suppressor cells... Full Text